Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Digoxin Tablets

Approval Number

国药准字H20227049

Company成都倍特得诺药业有限公司

Registration Date

April 12, 2022

Previous Approval Numbers

国药准字H51021112

Drug Information

Generic Name

地高辛片

Dosage Form

片剂

Strength

0.0625mg

Drug Type

化学药品

Registration Date

April 12, 2022

Company Information

Applicant Company

Company Name成都倍特得诺药业有限公司

Company Address

成都市温江区成都海峡两岸科技产业开发园科林路西段66号

Manufacturing Company

Company Name成都倍特得诺药业有限公司

Company Address

成都市温江区成都海峡两岸科技产业开发园区科林路西段

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy